Document:

EX-10.1

Exhibit 10.1

June 26, 2012

Jonathan E. Curley

Re: Your Separation From Symetra Life Insurance Company

Dear Jon:

As we have discussed, your employment with Symetra Life Insurance Company (“Symetra”) will end
on July 31, 2012. This Separation Agreement and General Release (“Agreement”) is intended to
clearly explain the terms related to the end of your employment with Symetra. By signing and
returning this Agreement, you will signify your agreement to these terms, and the Agreement will
become binding.

1. Separation from Employment. Your employment with Symetra will end effective July
31, 2012, which will be referred to as the “Separation Date.” You will receive your regular pay
and benefits through the Separation Date and payment will be made with the next regularly scheduled
payroll after your Separation Date. Normal payroll and withholding taxes will be deducted from
this payment.

2. Resignation as Officer. On the date of execution of this Agreement, you will
resign as an officer and/or director of Symetra and each of its affiliates, and will cease to earn
or accrue or participate in any plans or programs providing any compensation or benefits solely in
respect of service as an officer.

3. Transition. You agree to sign all documents needed to effectuate your separation
from Symetra and the transition of your job duties and responsibilities, no later than your
Separation Date.

4. Duties. From the date of execution of this Agreement, and until your Separation
Date, you will not be an executive, officer, or director of Symetra or any of its affiliates; no
other employee of Symetra will report to you; and you will only have such authority as specifically
assigned to you by Symetra.  

5. Accrued Vacation. Symetra will pay to you all of your accrued but unused vacation
earned up to the Separation Date. This payment will be made with the next regularly scheduled
payroll after your Separation Date. Normal payroll and withholding taxes will be deducted from
this payment.

6. 401(k) Plan. Following your Separation Date, you will retain any earned and vested
retirement benefits under Symetra’s 401(k) plan.

7. Annual Incentive Bonus. You will forfeit your 2012 Annual Incentive Bonus

8. Equity Plan. On your Separation Date, you will forfeit benefits under the Symetra
Financial Corporation Equity Plan, including your 2012 restricted stock awards, two-thirds of your
2011 restricted stock award, one-third of your 2010 restricted stock award and all performance
units and stock options. One-third of your 2011 restricted stock award (4,782 shares) and
two-thirds of your 2010 restricted stock award (7,309 shares) will vest on July 31, 2012.

9. Severance Payment. To assist you in your transition to new employment, and
according to your offer agreement dated October 7, 2010, Symetra will pay you, as severance pay, a
total of eight hundred and fifty-eight thousand dollars ($858,000), less applicable tax
withholdings and deductions, in a lump sum after the Effective Date of this Agreement.

10. Group Medical Benefits Coverage.  You and your dependents may elect a temporary
extension of group health plan coverage under the Consolidated Omnibus Budget Reconciliation Act of
1985, commonly known as “COBRA.” You will receive separate forms that describe your COBRA rights
and give you and your dependents the opportunity to continue your health insurance coverage.
Provided you timely and properly elect to continue your health insurance coverage through COBRA and
remain eligible for such coverage, Symetra will pay the employer COBRA premiums for six (6) months
for you and any covered dependents who were covered under your group medical benefits plan as of
your Separation Date.

11. No Other Payments. Except as described above, including payment for any unpaid
salary and benefits attributable to your employment prior to the Separation Date and reasonable
business expenses incurred by you on or before the Separation Date and not yet reimbursed, you
acknowledge and agree that you are not entitled to any other compensation, severance, benefits or
other payments in connection with your employment or positions with Symetra or the termination
thereof.

12. Return of Property. On or before your Separation Date, you will return to Symetra
all company-owned property in your possession, including without limitation all keys or access
cards to company buildings or property, all business credit cards, all passwords to Symetra’s
electronic communication systems or any password protected documents, all company-owned equipment
such as a laptop, printer, scanner or IPhone, and all Symetra documents and papers (such as,
without limitation, representative lists and strategic planning and financial documents), including
but not limited to trade secrets or confidential information. Any payment under this Agreement
will be delayed until you return all of Symetra’s property.

13. Release. In exchange for the severance pay and other benefits you receive under
this Agreement, you (on behalf of yourself and your marital community) irrevocably and
unconditionally waive and release Symetra and all of its parent, affiliated or subsidiary
organizations, any Symetra employee benefit plans and each of their respective directors, officers,
agents, trustees, employees, employee-spouses, successors and assigns (collectively referred to as
“the Symetra Releasees”), jointly and severally, from any and all claims, causes of action,
agreements, attorneys’ fees and costs, expenses, damages, promises, demands or otherwise
(“Claims”), whether known or unknown, in law or equity, accrued or unaccrued, contingent or
noncontingent, arising at any time up to and including the date you execute this Agreement. This
release includes, but is not limited to, and only by way of example:

	 	a.	 	all Claims arising from or relating to your employment or positions with
any of the Symetra Releasees, or the termination thereof;

	 	b.	 	any and all Claims arising under federal, state or local laws prohibiting
discrimination or harassment in employment including Title VII of the Civil Rights
Act of 1964, the Age Discrimination in Employment Act, the Americans with
Disabilities Act, the Family and Medical Leave Act, 42 U.S.C. § 1981, the State of
Washington Law Against Discrimination (RCW 49.60);

	 	c.	 	any and all Claims arising under the Employee Retirement Income and
Security Act of 1974, as amended, or any benefit plan, policy or program established
by Symetra;

	 	d.	 	any and all Claims arising under any federal, state or local law relating
to the payment of wages or other compensation or the hours of work, or any other
compensation in any form whatsoever from Symetra (except as provided by this
Agreement) including but not limited to any claims for wages, bonuses, commissions,
equity, vacation pay or other similar remuneration;

	 	e.	 	any and all tort or contract Claims or any other Claims arising from any
alleged legal restrictions of the right of Symetra to compensate, manage or terminate
its employees;

	 	f.	 	any and all Claims arising under any contract or agreement, whether written
or oral, between you and Symetra relating to any subject; and

	 	g.	 	any and all Claims arising under the common law of any jurisdiction,
including, but not limited to, all claims for breach of contract, defamation,
interference with contractual/prospective economic advantage, invasion of privacy,
promissory estoppel, negligence, breach of the covenant of good faith and fair
dealing, fraud, emotional distress, and wrongful discharge/termination.

This release does not prohibit you from filing an administrative charge with the Equal Employment
Opportunity Commission or assisting with a governmental investigation but shall constitute a
release and waiver of any claim or right to monetary damages or other relief in such a charge.

14. Agreement Not to Sue. You agree that you will not at any time maintain or file
any lawsuit or assert any claim against any Symetra Releasee for any damage or loss related in any
way to your employment or association with Symetra, except a claim to enforce this Agreement or a
charge with the EEOC as identified above.

15. Voluntary Agreement. This Agreement requires careful consideration. By signing
it, you are confirming that you do so voluntarily and you have not signed it as a result of any
coercion. You have 21 days after receipt of this Agreement to consider its terms and conditions.
You are encouraged to consult with an attorney prior to signing it. You should sign it only after
careful consideration. In the event that you sign this Agreement before the expiration of this
consideration period, you waive the rest of your consideration time.

16. Revocation Period. After you sign this Agreement, you have seven days to revoke
it. If you wish to revoke it, you must notify Christine Katzmar Holmes in writing within seven
days of signing the Agreement. This Agreement will be effective on the eighth day after you sign
it, which shall be referred to as the “Effective Date”.

17. References. All inquiries about you including any requests for reference
information must be directed to Symetra Human Resources, who will confirm your dates of employment,
position and duties. This is consistent with Symetra’s general policy regarding references.

18. Other Communications. You agree not to defame, or make any disparaging or untrue
statements that are intended to cause harm to Symetra or any of its shareholders, directors or
officers in any medium to any person or entity without limitation in time. Symetra shall control
the timing, content and manner of any internal, external and media communication concerning the
termination of your employment with Symetra. Symetra’s officers, speaking on behalf of the
corporation, shall not defame or make disparaging statements about you as well. 

19. No Admission of Liability. This Agreement will not be evidence of any violation
of any statute or law, or any wrongdoing or liability on the part of Symetra or its employees.

20. Confidentiality. By signing this Agreement, you agree to keep confidential and
not use or disclose any confidential, trade secret or any other information concerning Symetra, its
business, employees, marketing strategies and other information not publicly available. You also
agree to abide by any agreements with respect to confidentiality that you have signed. You must
also keep the terms of this Agreement confidential, except that you can share the information with
your spouse, attorney or accountant provided each promises to keep the information confidential.

21. Post Separation Assistance. Upon Symetra’s reasonable request, you agree to make
yourself available after your Separation Date to advise Symetra regarding matters you handled, or
about disputes with third parties with which you were familiar or involved. You also agree to
cooperate fully with Symetra in connection with all pending or threatened litigation, arbitration,
mediation, or similar proceedings in which you are or may be needed as a witness.

22. Entire Agreement. This Agreement contains the entire understanding between you
and Symetra regarding your departure from Symetra. By signing this Agreement, you acknowledge and
agree that you are not relying on any promise or representation, written or oral, other than those
that are specifically stated in this Agreement. If any provision of this Agreement is determined
to be invalid or unenforceable, the rest of this Agreement will remain enforceable. This Agreement
will be deemed to have been entered into in the State of Washington and will be interpreted and
enforced under Washington law.

As you review the terms of this Agreement, please contact me if you have any questions about
its terms.

Sincerely,

/s/ Christine Katzmar Holmes

Christine Katzmar Holmes

Senior Vice President, Human Resources and Administration

Symetra Life Insurance Company

I ACKNOWLEDGE AND UNDERSTAND THAT THE ABOVE AGREEMENT INCLUDES A RELEASE OF ALL CLAIMS, KNOWN AND
UNKNOWN, AND EXECUTE THIS AGREEMENT WITH FULL KNOWLEDGE OF ITS CONTENTS AND OPPORTUNITY FOR
CONSULTATION WITH LEGAL COUNSEL. I AGREE TO THE TERMS OF THIS AGREEMENT, AND ACKNOWLEDGE AND AGREE
THAT BY SIGNING BELOW THIS AGREEMENT IS A VALID AND BINDING AGREEMENT.

	 	 	 
	Dated: June 29, 2012
	 	/s/ Jonathan E. Curley

	 
	 	 

	 	 	Jonathan E. Curleyamtx_ex101.htm

EXHIBIT 10.1

 

 

 

 

STOCKHOLDERS’ AGREEMENT

 

by and between

 

AEMETIS, INC.

 

 

and

 

 

WESTERN MILLING INVESTORS, LLC,

 

AS SECURITYHOLDERS’ REPRESENTATIVE

 

 

Dated as of July 6, 2012

 

 

 

 

 

 

 

  

1

  

STOCKHOLDERS’ AGREEMENT

 

THIS STOCKHOLDERS’ AGREEMENT (this “Stockholders Agreement”) is made and entered into as of July 6, 2012, by and between Aemetis, Inc., a Nevada corporation (the “Company”) and Western Milling Investors, LLC, solely in its capacity as the Securityholders’ Representative acting on behalf of certain former holders of Series A Preferred and Series B Preferred Stock of Cilion, Inc., all of which are identified on Schedule I attached hereto (the “Cilion Stockholders”).  Reference is made to that certain Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”), by and among Company, AE Advanced Fuels, Inc., Keyes Facility Acquisition Corp. (“Merger Sub”), Cilion, Inc. (“Cilion”) and the Securityholders’ Representative.

 

W I T N E S S E T H

 

WHEREAS, this is the Stockholders’ Agreement referred to in the Merger Agreement;

WHEREAS, pursuant to the Merger Agreement, Company will acquire Cilion through the Merger of Merger Sub with and into Cilion, with Cilion being the surviving corporation;

WHEREAS, in the Merger, the capital stock of Cilion owned by the Cilion Stockholders will be converted into the right to receive Cash Merger Consideration and Stock Merger Consideration, all as more particularly set forth in the Merger Agreement;

WHEREAS, the Cilion Stockholders appointed the Securityholders’ Representative as their sole representative and agent to act on their behalf in regard to any matters arising under the Merger Agreement and this Stockholders Agreement; and

WHEREAS, the execution and delivery of this Agreement is a condition precedent to Cilion’s obligation to consummate the Merger Agreement and transactions contemplated thereby.

NOW, THEREFORE, in consideration of the foregoing and mutual covenants and agreements hereinafter set forth, and for other consideration, the receipt and sufficiency of which are hereby acknowledged, the parties to this Agreement hereby agree as follows:

ARTICLE I

OBSERVER RIGHTS

 

Section 1.1 Observer Rights.

 

(a) For a period of three (3) years following the date hereof, the Securityholders’ Representative, or its designee, shall be permitted to be present in a nonvoting observer capacity (the “Board Observer”) at all meetings of the Board of Directors (the “Board”) of the Company.  The Board Observer shall be entitled to receive copies of all notices, minutes, consents, and other materials that the Company provides to its directors at the same time and in the same manner as provided to such directors provided, however, that the Board Observer shall agree to hold in confidence and trust all information so provided.  Notwithstanding the foregoing, in the event the Securityholders’ Representative, or its designee, has not executed and delivered to the Company a confidentiality agreement in the form of Exhibit A attached hereto (the “Confidentiality Agreement”), the Company reserves the right to withhold any information and to exclude the Board Observer from any meeting or portion thereof if access to such information or attendance at such meeting could adversely affect the attorney-client privilege or attorney work product privilege between the Company and its counsel or result in disclosure of trade secrets or information of third parties the confidentiality of which the Company is obligated to maintain.

 

  

2

  

 

(b) The Company recognizes and acknowledges that the Securityholders’ Representative and the Cilion Stockholders may now or in the future be engaged in the research, development, production, marketing, licensing and/or sale of similar services or products to those being researched, developed, produced, marketed, licensed and/or sold by the Company and its Subsidiaries.  Nothing in this Stockholders’ Agreement shall be construed to prevent the Securityholders’ Representative and the Cilion Stockholders from engaging independently in such activities.

 

(c) Nothing contained in this Stockholders’ Agreement shall be construed as preventing Securityholders’ Representative from distributing such information to the Cilion Stockholders, which Securityholders’ Representative may elect to do in its sole discretion but only if the Cilion Stockholder receiving such information has signed the Confidentiality Agreement or a similar form of confidentiality agreement.  For purposes of this Stockholders’ Agreement, the term “Material Confidential Information” means material nonpublic information under Regulation FD.

 

ARTICLE II

REGULATORY COMPLIANCE

 

Unless otherwise specified in this Article II, the Company covenants with Securityholders’ Representative as follows, which covenants are for the benefit of each Cilion Stockholder and their respective permitted assignees.

 

Section 2.1 Applicable Regulatory Compliance.

 

(a) The Company agrees to provide, or cause to be provided, to the Securityholders’ Representative, or its designee(s), as promptly as reasonably practicable upon written request therefor, any information in the possession or under the control of the Company or its Subsidiaries to the extent (i) reasonably necessary to allow the Cilion Stockholders to comply with reporting, disclosure, filing or other requirements imposed on it or its Affiliates by a Governmental Authority having jurisdiction over it, including under applicable securities or tax laws, including the Sarbanes-Oxley Act of 2002 and the rules and regulations thereunder, or applicable rules of any Self-Regulatory Organization (collectively, the “Applicable Regulatory Requirements”); (ii) reasonably required for use by the Securityholders’ Representative and/or Cilion Stockholders in any judicial, regulatory, administrative, tax or other proceeding; or (iii) reasonably required in order to satisfy any audit, accounting, claims, regulatory, litigation, tax or other similar requirements; provided that the Company shall have the right to redact any Company Material Confidential Information.

 

  

3

  

 

(b) The Company will maintain true books and records of account in which full and correct entries will be made of all its business transactions pursuant to a system of accounting established and administered in accordance with GAAP, consistently applied, and will set aside on its books such accruals and reserves as may be required under GAAP.

 

(c) The Company shall use commercially reasonable efforts to maintain systems of disclosure controls and procedures and internal control over financial reporting, to the extent and only to the extent if such systems are reasonably required to enable the Securityholders’ Representative to satisfy its obligations under applicable securities laws, including under the Sarbanes-Oxley Act of 2002 and the rules and regulations thereunder.

 

Section 2.2 Securities Compliance. The Company shall notify the SEC in accordance with its rules and regulations, of the transactions contemplated by the Merger Agreement and this Stockholders Agreement and shall take all other necessary action and proceedings as may be required and permitted by applicable law, rule and regulation, for the legal and valid issuance of the Stock Merger Consideration to the Cilion Stockholders.

 

Section 2.3 Reporting Requirements. If the Company has not filed its periodic reports with the SEC, or if the SEC ceases making these periodic reports available via the Internet without charge, then the Company shall furnish the following to the Securityholders’ Representative:

 

(a) as soon as practicable, but in any event within ninety (90) days after the end of each fiscal year of the Company, (i) a balance sheet as of the end of such year, (ii) statements of income and of cash flows for such year, and a comparison between (x) the actual amounts as of and for such fiscal year and (y) the comparable amounts for the prior year and as included in the Budget (as defined below) for such year, with an explanation of any material differences between such amounts and a schedule as to the sources and applications of funds for such year, and (iii) a statement of stockholders’ equity as of the end of such year, all such financial statements audited and certified by independent public accountants selected by the Board.

 

(b) as soon as practicable, but in any event within forty five (45) days after the end of each of the first three (3) quarters of each fiscal year of the Company, unaudited statements of income and of cash flows for such fiscal quarter, and an unaudited balance sheet and a statement of stockholders’ equity as of the end of such fiscal quarter, all prepared in accordance with GAAP (except that such financial statements may (i) be subject to normal year-end audit adjustments and (ii) not contain all notes thereto that may be required in accordance with GAAP);

 

(c) as soon as practicable, but in any event thirty (30) days before the end of each fiscal year, a budget and business plan for the next fiscal year for the Company (collectively, the “Budget”), approved by the Board and prepared on a monthly basis, including balance sheets, income statements, and statements of cash flow for such months and, promptly after prepared, any other budgets or revised budgets prepared by the Company; and

 

  

4

  

 

(d) if, for any period, the Company has any Subsidiary whose accounts are consolidated with those of the Company, then in respect of such period the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such consolidated Subsidiaries.

 

ARTICLE III

REGISTRATION RIGHTS

 

Registration Rights.  The Company covenants and agrees as follows:

 

Section 3.1 Definitions.  For purposes of this Article III:

 

(a) The term “Act” means the Securities Act of 1933, as amended.

 

(b) The term “Form S-3” means such form under the Act as in effect on the date hereof or any registration form under the Act subsequently adopted by the SEC that permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC.

 

(c) The term “Holder” means any person owning or having the right to acquire Registrable Securities or any assignee thereof in accordance with Section 3.9 hereof.

 

(d) The term “Initial Offering” means the Company’s first firm commitment underwritten public offering of its Common Stock under the Act that results in the conversion of the Company’s outstanding Preferred Stock into Common Stock in accordance with the provisions of the Company’s Amended and Restated Certificate of Incorporation.

 

(e) The term “Other Holder” means any other Company stockholder to whom the Company has granted registration rights.

 

(f) The term “1934 Act” means the Securities Exchange Act of 1934, as amended.

 

(g) The terms “register,” “registered,” and “registration” refer to a registration effected by preparing and filing a registration statement or similar document in compliance with the Act, and the declaration or ordering of effectiveness of such registration statement or document.

 

(h) The term “Registrable Securities” means (i) the shares of the Company’s common stock issued to the Cilion Stockholders pursuant to the Merger Agreement (the “Merger Shares”), (ii) any capital stock of the Company issued or issuable as a dividend or other distribution with respect to, or in exchange for, or in replacement of, the Merger Shares, whether by stock split, recapitalization, merger, consolidation or otherwise, until the registration rights granted by this Agreement with respect to the Merger Shares have terminated in accordance with this Agreement.

 

(i) The term “Rule 144” shall mean Rule 144 under the Act.

 

(j) The term “SEC” shall mean the Securities and Exchange Commission.

 

  

5

  

 

Section 3.2 Company Registration.

 

(a) If (but without any obligation to do so) the Company proposes to register any of its stock or other securities under the Act in connection with the public offering of such securities (other than a registration relating solely to the sale of securities of participants in a Company employee benefit plan, a registration covering only securities proposed to be issued in exchange for securities or assets of another corporation, or a registration in which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered), the Company shall, at such time, promptly give each Holder written notice of such registration.  Upon the written request of each Holder given within twenty (20) days after such notice is delivered to such Holder in accordance with Section 3.5, the Company shall, subject to the provisions of Section 3.2(c), use best efforts to cause to be registered under the Act all of the Registrable Securities that each such Holder requests to be registered.

 

(b) Right to Terminate Registration.  The Company shall have the right to terminate or withdraw any registration initiated by it under this Section 3.2 prior to the effectiveness of such registration whether or not any Holder has elected to include securities in such registration.  The expenses of such withdrawn registration shall be borne by the Company in accordance with Section 3.6 hereof.

 

(c) Underwriting Requirements.  In connection with any offering involving an underwriting of shares of the Company’s capital stock, the Company shall not be required under this Section 3.2 to include any of the Holders’ securities in such underwriting unless they accept the terms of the underwriting as agreed upon between the Company and the underwriters selected by the Company (or by other persons entitled to select the underwriters) and enter into an underwriting agreement in customary form with such underwriters, and then, subject to the remaining provisions of this Section 3.2(c), only in such quantity as the underwriters determine in their sole discretion will not jeopardize the success of the offering by the Company.  If the managing underwriters advise the Company in writing that in their opinion the number of securities requested to be included in such registration exceeds the number which can be sold in such offering without adversely affecting the marketability of the offering, the Company will include in such registration only the amount of securities which the managing underwriters have advised can be sold, and will allocate such amount, first, to the amount of securities the Company proposes to sell and second, pro rata among the Holders and Other Holders based on the number of shares held by all such Holders and Other Holders or in such other proportions as shall mutually be agreed to by all such selling holders.  For purposes of the preceding sentence concerning apportionment, for any selling stockholder that is a Holder of Registrable Securities and that is a venture capital fund, partnership or corporation, the affiliated venture capital funds, partners, retired partners and stockholders of such Holder, or the estates and family members of any such partners and retired partners and any trusts for the benefit of any of the foregoing persons shall be deemed to be a single “selling Holder,” and any pro rata reduction with respect to such “selling Holder” shall be based upon the aggregate amount of Registrable Securities owned by all such related entities and individuals.

 

  

6

  

 

Section 3.3 Demand Registration.  In case the Company shall receive from the Holders of at least twenty-five percent (25%) of the Registrable Securities (for purposes of this Section 3.3, the “Initiating Holders”) a written request or requests that the Company effect a registration on Form S-3 and any related qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder, the Company shall:

 

(a) promptly give written notice of the proposed registration, and any related qualification or compliance, to all Holders; and

 

(b) prepare and file with the SEC a registration statement with respect to such Registrable Securities and any other securities for which registration has been requested by Other Holders within ninety (90) days after any written request for registration, and use its best efforts to cause such registration statement to become effective (provided, that before filing a registration statement or prospectus or any amendments or supplements thereto, the Company will furnish to a single counsel selected by the Holders and Other Holders copies of all such documents proposed to be filed, which documents will be subject to review and approval of such counsel), use its best efforts to file all such qualifications as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such Holders’ Registrable Securities as are specified in such request (and to avoid the issuance of (or if issued, obtain the withdrawal of) any order suspending the effectiveness of a registration statement, or the lifting of any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale in any jurisdiction as soon as possible), and, together with all or such portion of the Registrable Securities of any Holders or Other Holders joining in such request as are specified in a written request given within fifteen (15) days after such notice from the Company is delivered to such Holder, provided, however, that the Company shall not be obligated to effect any such registration, qualification or compliance, pursuant to this Section 3.3:

 

(i) if Form S-3 is not available for such offering by the Holders;

 

(ii) if the Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose to sell Registrable Securities and such other securities (if any) at an aggregate price to the public of less than $5,000,000;

 

(iii) if the Company shall furnish to Holders requesting a registration statement pursuant to this Section 3.3 a certificate signed by the Company’s Chief Executive Officer or Chairman of the Board stating that in the good faith judgment of the Board of Directors of the Company, it would be materially detrimental to the Company and its stockholders for such registration statement to be effected at such time, in which event the Company shall have the right to defer such filing for a period of not more than ninety (90) days after receipt of the request of the Initiating Holders, provided that such right shall be exercised by the Company not more than once in any twelve (12)-month period;

 

(iv) if the Company has, within the six (6) month period preceding the date of such request, already effected one registration on Form S-3 for the Holders pursuant to this Section 3.3;

 

  

7

  

 

(v) if the Company has already effected four registrations on Form S-3 for the Holders pursuant to this Section 3.3; or

 

(vi) in any particular jurisdiction in which the Company would be required to qualify to do business or to execute a general consent to service of process in effecting such registration, qualification or compliance.

 

(c) If the Initiating Holders intend to distribute the Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to this Section 3.3 and the Company shall include such information in the written notice referred to in Section 3.3(a).  The provisions of Section 3.2(b) shall be applicable to such request (with the substitution of Section 3.3 for references to Section 3.2).

 

Section 3.4 Obligations of the Company.  Whenever required under this Article III to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible:

 

(a) prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Act with respect to the disposition of all securities covered by such registration statement during such period, which period shall not be less than six (6) months;

 

(b) furnish to the Holders such number of copies of a prospectus, including a preliminary prospectus, each amendment and supplement thereto, in conformity with the requirements of the Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them;

 

(c) use its best efforts to register and qualify the securities covered by such registration statement under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions;

 

(d) in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing underwriter of such offering and take all such other actions as the Holders or the underwriters reasonably request in order to expedite or facilitate the disposition of such Registrable Securities;

 

(e) notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is required to be delivered under the Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing and, at the request of any such seller, the Company will prepare a supplement or amendment to such prospectus so that, as thereafter delivered to the purchasers of such Registrable Securities, such prospectus will not contain an untrue statement of a material fact or omit to state any fact necessary to make the statement therein not misleading;

 

  

8

  

 

(f) cause all such Registrable Securities registered pursuant to this Article III to be listed on a national exchange or trading system and on each securities exchange and trading system on which similar securities issued by the Company are then listed;

 

(g) provide a transfer agent and registrar for all Registrable Securities registered pursuant hereunder and a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration;

 

(h) make available for inspection by any Holder, any underwriter participating in any disposition pursuant to such registration statement, and any attorney, accountant or other agent retained by any Holder or underwriter, all financial and other records, pertinent corporate documents and properties of the Company, and cause the Company’s officers, directors, employees and independent accountants to supply all information reasonably requested by any such seller, underwriter, attorney, accountant or agent in connection with such registration statement; and

 

(i) obtain a cold comfort letter from the Company’s independent public accountants in customary form and covering such matters customarily given or covered by independent public accountants in an underwritten public offering of securities, addressed to the Holders.

 

(j) Notwithstanding the provisions of this Article III, the Company shall be entitled to postpone or suspend, for a reasonable period of time (and in no event in excess of 90 days), the filing, effectiveness or use of, or trading under, any registration statement if the Company shall determine that any such filing or the sale of any securities pursuant to such registration statement would in the good faith judgment of the Board of Directors of the Company require disclosure of material nonpublic information that, if disclosed at such time, would be materially harmful to the interests of the Company and its stockholders; provided, however, that during any such period all executive officers and directors of the Company are also prohibited from selling securities of the Company (or any security of any of the Company’s subsidiaries or affiliates).  In the event of the suspension of effectiveness of any registration statement pursuant to this Section 3.4, the applicable time period during which such registration statement is to remain effective shall be extended by that number of days equal to the number of days the effectiveness of such registration statement was suspended.  No more than one (1) such suspension may be initiated in any twelve (12) month period.

 

Section 3.5 Information from Holder.  It shall be a condition precedent to the obligations of the Company to take any action pursuant to this Article III with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of such securities as shall be reasonably required to effect the registration of such Holder’s Registrable Securities.

 

  

9

  

 

Section 3.6 Expenses of Registration.  All expenses other than underwriting discounts and commissions incurred in connection with registrations, filings or qualifications pursuant to Sections 3.2 and 3.3, including (without limitation) all registration, filing and qualification fees, printers’ and accounting fees, fees and disbursements of counsel for the Company and the reasonable fees and disbursements of one counsel for the selling Holders (which counsel shall be selected by selling Holders and Other Holders holding a majority of the securities included in such registration) shall be borne by the Company.  Notwithstanding the foregoing, the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Section 3.2 or Section 3.3 if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered (in which case all participating Holders shall bear such expenses pro rata based upon the number of Registrable Securities that were to be included in the withdrawn registration), unless, in the case of a registration requested under Section 3.3, the Holders of a majority of the Registrable Securities agree to forfeit their right to one registration pursuant to Section 3.3 and provided, however, that if at the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business or prospects of the Company from that known to the Holders at the time of their request and have withdrawn the request with reasonable promptness following their discovery of such material adverse change, then the Holders shall not be required to pay any of such expenses and shall retain their rights pursuant to Section 3.3.

 

Section 3.7 Delay of Registration.  No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Article III.

 

Section 3.8 Indemnification.  In the event any Registrable Securities are included in a registration statement under this Article III:

 

(a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder, the partners, officers, directors and stockholders of each Holder, legal counsel and accountants for each Holder, any underwriter (as defined in the Act) for such Holder and each person, if any, who controls such Holder or underwriter within the meaning of the Act or the 1934 Act, against any losses, claims, damages or liabilities (joint or several) to which they may become subject under the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a “Violation”):  (i) any untrue statement or alleged untrue statement of a material fact contained in such registration statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto, (ii) the omission or alleged omission to state in such registration statement a material fact required to be stated therein, or necessary to make the statements therein not misleading or (iii) any violation or alleged violation by the Company of the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act, the 1934 Act or any state securities laws,  and the Company will reimburse each such Holder, underwriter, controlling person or other aforementioned person for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action as such expenses are incurred; provided, however, that the indemnity agreement contained in this subsection 3.8(a) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon a Violation that occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such registration by any such Holder, underwriter, controlling person or other aforementioned person; provided further, however, that the foregoing indemnity agreement with respect to any preliminary prospectus shall not inure to the benefit of any Holder or underwriter or other aforementioned person, or any person controlling such Holder or underwriter, from whom the person asserting any such losses, claims, damages or liabilities purchased shares in the offering, if a copy of the most current prospectus was not sent or given by or on behalf of such Holder or underwriter or other aforementioned person to such person, if required by law to have been so delivered, at or prior to the written confirmation of the sale of the shares to such person, and if the prospectus (as so amended or supplemented) would have cured the defect giving rise to such loss, claim, damage or liability.

 

  

10

  

 

(b) To the extent permitted by law, each selling Holder will indemnify and hold harmless the Company, each of its directors, each of its officers who has signed the registration statement, each person, if any, who controls the Company within the meaning of the Act, legal counsel and accountants for the Company, any underwriter, any other Holder selling securities in such registration statement and any controlling person of any such underwriter or other Holder, against any losses, claims, damages or liabilities (joint or several) to which any of the foregoing persons may become subject, under the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated under the Act, the 1934 Act or any state securities laws, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder expressly for use in connection with such registration; and each such Holder will reimburse any person intended to be indemnified pursuant to this subsection 3.8(b) for any legal or other expenses reasonably incurred by such person in connection with investigating or defending any such loss, claim, damage, liability or action as such expenses are incurred; provided, however, that the indemnity agreement contained in this subsection 3.8(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder (which consent shall not be unreasonably withheld), and provided that in no event shall any indemnity under this subsection 3.8(b) exceed the net proceeds from the offering received by such Holder.

 

(c) Promptly after receipt by an indemnified party under this Section 3.8 of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 3.8, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such proceeding.  The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if prejudicial to its ability to defend such action, shall relieve such indemnifying party of liability to the indemnified party under this Section 3.8 to the extent of such prejudice, but the omission to so deliver written notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Section 3.8.

 

  

11

  

 

(d) If the indemnification provided for in this Section 3.8 is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to herein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and the indemnified party on the other hand in connection with the statements or omissions that resulted in such loss, liability, claim, damage or expense, as well as any other relevant equitable considerations; provided, however, that no contribution by any Holder, when combined with any amounts paid by such Holder pursuant to Section 3.8(b), shall exceed the net proceeds from the offering received by such Holder.  The relative fault of the indemnifying party and the indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.

 

(e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control.

 

(f) The obligations of the Company and Holders under this Section 3.8 shall survive the completion of any offering of Registrable Securities in a registration statement under this Article III and otherwise.

 

Section 3.9 Assignment of Registration Rights.  The rights to cause the Company to register Registrable Securities pursuant to this Article III may be assigned (but only with all related obligations) by a Holder to a transferee or assignee of such securities that (i) is a subsidiary, parent, partner, limited partner, retired partner, member, former member, stockholder or affiliate of a Holder, (ii) is a Holder’s family member or trust for the benefit of an individual Holder, or (iii) after such assignment or transfer, holds at least 25% of the Registrable Securities (subject to appropriate adjustment for stock splits, stock dividends, combinations or the like) held by such Holder immediately prior to such assignment or transfer, provided:  (a) the transferee or assignee is not a direct competitor of the Company or an affiliate of a direct competitor of the Company, (b) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such transferee or assignee and the securities with respect to which such registration rights are being assigned and (c) such transferee or assignee agrees in writing to be bound by and subject to the terms and conditions of this Agreement.

 

  

12

  

 

Section 3.10  “Market Stand-Off” Agreement.

 

(a) Each Holder hereby agrees that it will not, without the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus relating to the Company’s Initial Offering and ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred eighty (180) days) (i) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock held immediately prior to the effectiveness of the Registration Statement for such offering, or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Common Stock, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or other securities, in cash or otherwise.  The foregoing provisions of this Section 3.10 shall apply only to the Initial Offering of equity securities, and shall (i) not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, (ii) not apply to any Holder that owns less than one percent of the issued and outstanding common stock of the Company, and (iii) only be applicable to the Holders if all officers, directors and greater than one percent (1%) stockholders of the Company enter into similar agreements.  The underwriters in connection with the Company’s Initial Offering are intended third-party beneficiaries of this Section 3.10 and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto.  Each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in the Company’s Initial Offering that are consistent with this Section 3.10 or that are necessary to give further effect thereto.  Notwithstanding the foregoing, the prior written consent of the managing underwriter shall not be required for an assignment of any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock by a Holder to a transferee or assignee that is a subsidiary, parent, partner, limited partner, retired partner, member, former member, stockholder or affiliate of a Holder, provided however, that such transferee or assignee agrees in writing to be bound by and subject to the provisions of this Section 3.10.

 

In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to the Registrable Securities of each Holder (and the shares or securities of every other person subject to the foregoing restriction) until the end of such period.

 

(b) Each Holder that owns more than one percent of the issued and outstanding common stock of the Company agrees that a legend reading substantially as follows shall be placed on all certificates representing all Registrable Securities of each Holder (and the shares or securities of every other person subject to the restriction contained in this Section 3.10):

 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD OF UP TO 180 DAYS AFTER THE EFFECTIVE DATE OF THE ISSUER’S REGISTRATION STATEMENT FILED UNDER THE ACT, AS AMENDED, AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL HOLDER OF THESE SECURITIES, A COPY OF WHICH MAY BE OBTAINED AT THE ISSUER’S PRINCIPAL OFFICE.  SUCH LOCK-UP PERIOD IS BINDING ON TRANSFEREES OF THESE SHARES.

 

  

13

  

 

Section 3.11 Termination of Rights.  No Holder shall be entitled to exercise any right provided for in this Agreement after three (3) years following the consummation of the Initial Offering, or (ii) as to any Holder, such earlier time after the Initial Offering at which such Holder (A) can sell all shares held by it in compliance with Rule 144 or (B) holds one percent (1%) or less of the Company’s outstanding Common Stock and all Registrable Securities held by such Holder (together with any affiliate of the Holder with whom such Holder must aggregate its sales under Rule 144) can be sold in any three (3)-month period without registration in compliance with Rule 144.

 

ARTICLE IV

Miscellaneous

 

Section 4.1 Successors and Assigns.  Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties (including transferees of any shares of Registrable Securities).  Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

Section 4.2 Governing Law.  This Agreement shall be governed by and construed under the laws of the State of Delaware.

 

Section 4.3 Counterparts.  This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

Section 4.4 Titles and Subtitles.  The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.

 

Section 4.5 Notices. All notices and other communications given or made pursuant hereto shall be in writing and shall be deemed effectively given:  (i) upon personal delivery to the party to be notified, (ii) when sent by confirmed electronic mail or facsimile if sent during normal business hours of the recipient; if not, then on the next business day, (iii) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt.  All communications shall be sent to the respective parties at the addresses set forth on the signature pages attached hereto (or at such other addresses as shall be specified by notice given in accordance with this Section 4.5).

 

  

14

  

 

Section 4.6 Expenses.  If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.

 

Section 4.7 Entire Agreement; Amendments and Waivers.  This Agreement (including the Exhibits hereto, if any) constitutes the full and entire understanding and agreement among the parties with regard to the subjects hereof and thereof.  Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively) only with the written consent of the Company and the Securityholders’ Representative.  Any amendment or waiver effected in accordance with this paragraph shall be binding upon each holder of any Registrable Securities, each future holder of all such Registrable Securities, and the Company.

 

Section 4.8 Severability.  If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision(s) shall be excluded from this Agreement and the balance of the Agreement shall be interpreted as if such provision(s) were so excluded and shall be enforceable in accordance with its terms.

 

Section 4.9 Aggregation of Stock.  All shares of Registrable Securities held or acquired by affiliated entities (including affiliated venture capital funds) or persons shall be aggregated together for the purpose of determining the availability of any rights under this Agreement.

 

  

15

  

 

IN WITNESS WHEREOF, the parties have executed this Stockholders’ Agreement as of the date first written above.

 

	 	COMPANY:
	 	 
	 	AEMETIS, INC.
	 	 
	 	By:      /s/ Eric A. McAfee                                            
	 	   Name: Eric A. McAfee
	 	   Title: Chief Executive Officer
	 	 
	 	ADDRESS: 

____________________________________

____________________________________

____________________________________

	 	 
	 	
SECURITYHOLDERS’ REPRESENTATIVE

 

WESTERN MILLING INVESTORS, LLC

	 	 
	 	By:     /s/ Kevin Kruse                                                 
	 	   Name: Kevin Kruse
	 	   Title: Manager
	 	 
	 	ADDRESS: 

____________________________________

____________________________________

____________________________________

 

16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}]]